The results showed that serum IL-27 levels increased in second trimester among individuals who experienced adverse pregnancy outcomes; however, there was no significant difference in serum IL-27 levels between non-GDM and GDM (Figure 1A; Supplementary Table S1), suggesting that IL-27 was not specifically associated with GDM but with adverse pregnancy outcomes. This evidence concerns the gene IL27 and gestational diabetes.